Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody-Reference-Cited by-同舟云学术

Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody

Published:2017-12-04 Issue:3 Volume:67 Page:459-470
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Suh Koung Jin,Kim Se Hyun,Kim Yu Jung,Kim Miso,Keam Bhumsuk,Kim Tae Min,Kim Dong-Wan,Heo Dae Seog,Lee Jong Seok

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s00262-017-2092-x/fulltext.html

Reference35 articles.

1. Suh KJ, Kim SH, Kim YJ et al (2017) P3.02c-061 Neutrophil/lymphocyte ratio predicts the efficacy of anti-PD-1 antibody in patients with advanced lung cancer. J Thorac Oncol 12:S1312–S1313. https://doi.org/10.1016/j.jtho.2016.11.1856 (poster)

2. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674. https://doi.org/10.1016/j.cell.2011.02.013

3. Templeton AJ, McNamara MG, Šeruga B et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 106:dju124. https://doi.org/10.1093/jnci/dju124

4. Hu B, Yang X-R, Xu Y, Sun Y-F, Sun C, Guo W, Zhang X, Wang W-M, Qiu S-J, Zhou J, Fan J (2014) Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res 20:6212–6222. https://doi.org/10.1158/1078-0432.CCR-14-0442

5. Yang Z, Zhang J, Lu Y, Xu Q, Tang B, Wang Q, Zhang W, Chen S, Lu L, Chen X (2015) Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization. Oncotarget 6:43090–43098. https://doi.org/10.18632/oncotarget.5719

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancer;Scientific Reports;2024-08-23

2. The Glasgow Prognostic Score as a Predictor of Survival after Chemoradiotherapy for Limited-Disease Small Cell Lung Cancer;Oncology;2024-08-05

3. Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy;Expert Opinion on Pharmacotherapy;2024-07-23

4. Lymphocyte activation markers predict the therapeutic response to immune checkpoint inhibitors: A case–control study;Cancer Medicine;2024-06

5. Predictors of Immunotherapy Efficacy in Metastatic Non-Small Cell Lung Cancer: Lung Immune Prognostic Index and Immune-Related Toxicity;World Journal of Oncology;2024-04